Original article
Impact of systemic inflammatory markers in patients with ALK-positive non-small cell lung cancer treated with crizotinib
O.F. Olmeza, A. Bilicia, P. Gursoyb, E. Cubukcuc, A. Sakind, T. Korkmaze, I. Cilf, B. Cakarb, S. Menekseg, T. Demirh, O. Acikgoza, J. Hamdarda,
Corresponding author
olmezof@gmail.com
Corresponding author at: Department of Medical Oncology, Medipol University Faculty of Medicine, Istanbul, Turkey.
Corresponding author at: Department of Medical Oncology, Medipol University Faculty of Medicine, Istanbul, Turkey.
a Department of Medical Oncology, Medipol University Faculty of Medicine, Istanbul, Turkey
b Ege University Faculty of Medicine, Izmir, Turkey
c Uludag University Faculty of Medicine, Bursa, Turkey
d University of Health Sciences Okmeydani Training and Research Hospital, Istanbul, Turkey
e Acıbadem University Faculty of Medicine, Istanbul, Turkey
f Bakirkoy Dr. Sadi Konuk Training and Research Hospital, Istanbul, Turkey
g Bagcilar Training and Research Hospital, Istanbul, Turkey
h Bezmialem University Faculty of Medicine, Istanbul; Turkey
Read
266
Timeswas read the article
93
Total PDF
147
Total HTML
26
Total EPUB
| Year/Month | Html | Epub | Total | |
|---|---|---|---|---|
| 2023 March | 44 | 12 | 4 | 60 |
| 2023 February | 21 | 19 | 7 | 47 |
| 2023 January | 47 | 37 | 10 | 94 |
| 2022 December | 35 | 25 | 5 | 65 |
